129
Views
3
CrossRef citations to date
0
Altmetric
Study Protocol

Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naïve Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Trial (LOGiK2004)

, , ORCID Icon &
Pages 8489-8493 | Published online: 11 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jianghua Ding, Xinjing Ding & Zhaohui Leng. (2023) Immunotherapy-based therapy as a promising treatment for EGFR-mutant advanced non-small cell lung cancer patients after EGFR-TKI resistance. Expert Review of Anticancer Therapy 23:2, pages 187-198.
Read now

Articles from other publishers (2)

Dairan Zhou, Zhenyu Gong, Dejun Wu, Chao Ma, Lijun Hou, Xiaomin Niu & Tao Xu. (2023) Harnessing immunotherapy for brain metastases: insights into tumor–brain microenvironment interactions and emerging treatment modalities. Journal of Hematology & Oncology 16:1.
Crossref
Fabian Acker, Friederike C. Althoff & Martin Sebastian. (2023) Systemic Treatment for Brain Metastases in NSCLC: A New Chapter. Journal of Thoracic Oncology 18:6, pages 678-681.
Crossref